Clinical Trial Update: Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL [Phase 2, Phase 3]

View source ↗

Summary

A study evaluating R-IDARAM and intrathecal immunochemotherapy for elderly patients with primary central nervous system lymphoma is in Phase 2/Phase 3 and curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• R-IDARAM

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Primary Central Nervous System Lymphoma | Phase 2, Phase 3 | Status: RECRUITING